| 000 | 01355 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515234234.0 | ||
| 264 | 0 | _c20110121 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dkq292 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRose, Warren E | |
| 245 | 0 | 0 |
_aPharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cOct 2010 |
||
| 300 |
_a2149-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aCell Wall _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xmicrobiology |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVancomycin _xpharmacokinetics |
| 650 | 0 | 4 | _aVancomycin Resistance |
| 700 | 1 | _aKnier, Ryan M | |
| 700 | 1 | _aHutson, Paul R | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 65 _gno. 10 _gp. 2149-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkq292 _zAvailable from publisher's website |
| 999 |
_c20031623 _d20031623 |
||